152 - References

References

158 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 References

1. Rogers JP, et al. Evidence-­based consensus guidelines for the management of catatonia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2023; 37:327–369.
2. Solmi M, et al. Prevalence of catatonia and its moderators in clinical samples: results from a meta-­analysis and meta-­regression analysis. Schizophr Bull 2018; 44:1133–1150.
3. Morrison JR. Catatonia. Retarded and excited types. Arch Gen Psychiatry 1973; 28:39–41.
4. Walther S, et al. Structure and neural mechanisms of catatonia. Lancet Psychiatry 2019; 6:610–619.
5. Mann SC, et al. Catatonia, malignant catatonia, and neuroleptic malignant syndrome. Current Psychiatry Reviews 2013; 9:111–119.
6. Takacs R, et al. Catatonia in affective disorders. Current Psychiatry Reviews 2013; 9:101–105.
7. Mangas MCC, et al. P-­167: catatonia in bipolar disorder. Eur Psychiatry 2012; 27 Suppl 1:1.
8. Huang YC, et al. Rapid relief of catatonia in mood disorder by lorazepam and diazepam. Biomed J 2013; 36:35–39.
9. Vasudev K, et al. What works for delirious catatonic mania? BMJ Case Rep 2010; 2010:bcr0220102713.
10. Neuhut R, et al. Resolution of catatonia after treatment with stimulant medication in a patient with bipolar disorder. Psychosomatics 2012; 53:482–484.
11. Ghaffarinejad AR, et al. Periodic catatonia: challenging diagnosis for psychiatrists. Neurosciences (Riyadh) 2012; 17:156–158.
12. Oldham MA, et al. Alcohol and sedative-­hypnotic withdrawal catatonia: two case reports, systematic literature review, and suggestion of a potential relationship with alcohol withdrawal delirium. Psychosomatics 2016; 57:246–255.
13. Banerjee D. Etizolam withdrawal catatonia: the first case report. Asian J Psychiatr 2018; 37:32–33.
14. Fink M. Rediscovering catatonia: the biography of a treatable syndrome. Acta Psychiatr Scand Suppl 2013; (441):1–47.
15. Bartolommei N, et al. Catatonia: a critical review and therapeutic recommendation. J Psychopathol 2012; 18:234–246.
16. Lee J. Dissociative catatonia: dissociative-­catatonic reactions, clinical presentations and responses to benzodiazepines. Aust N Z J Psychiatry 2011; 45:A42.
17. Suzuki K, et al. Hysteria presenting as a prodrome to catatonic stupor in a depressive patient resolved with electroconvulsive therapy. J ECT 2006; 22:276.
18. Alwaki A, et al. Catatonia: an elusive diagnosis. Neurology 2013; 80 Suppl 1:P05.127.
19. Dhadphale M. Eye gaze diagnostic sign in hysterical stupor. Lancet 1980; 2:374–375.
20. Gomez J. Hysterical stupor and death. Br J Psychiatry 1980; 136:105–106.
21. Petrides G, et al. Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia. Biol Psychiatry 1997; 42:375–381.
22. Nahar A, et al. Catatonia among women with postpartum psychosis in a mother–baby inpatient psychiatry unit. Gen Hosp Psychiatry 2017; 45:40–43.
23. Csihi L, et al. Catatonia during pregnancy and the postpartum period. Schizophr Res 2024; 263:257–264.
24. Delvi A, et al. Catatonia in the peripartum: a cohort study using electronic health records. Schizophr Res 2024; 263:252–256. Table 1.34  Medications other than benzodiazepines reported as treatments for catatonia/stupor (listed in alphabetical order – no ranking or judgement is implied by the order). Antipsychotic medications1,78–84,94–97 aripiprazole clozapine olanzapine risperidone ziprasidone Experimental treatments*9,10,43,44,64,98–103 amantadine amitriptyline carbamazepine fluoxetine fluvoxamine lithium memantine methylphenidate mirtazapine tramadol valproate zolpidem * Always read the primary literature before using any of the medications listed in this section.

Schizophrenia and related psychoses CHAPTER 1 25. Biles TR, et al. Should catatonia be conceptualized as a pathological response to trauma? J Nerv Ment Dis 2021; 209:320–323. 26. Bonomo N, et al. Rapid resolution of catatonia secondary to post traumatic stress disorder with secondary psychotic features through scheduled zolpidem tartrate. BMC Psychiatry 2023; 23:258. 27. Mazzone L, et al. Catatonia in patients with autism: prevalence and management. CNS Drugs 2014; 28:205–215. 28. Dhossche DM, et al. Catatonia in psychiatric illnesses. In: Fatemi SH, Clayton PJ, eds. The Medical Basis of Psychiatry. Totowa, NJ: Humana Press; 2008:471–486. 29. Shetageri VN, et al. Case report: catatonia as a presenting symptom of Wilsons disease. Indian J Psychiatry 2011; 53 Suppl 5:S93–S94. 30. Cardinal RN, et al. Psychosis and catatonia as a first presentation of antiphospholipid syndrome. Br J Psychiatry 2009; 195:272. 31. Rogers JP, et al. Catatonia and the immune system: a review. Lancet Psychiatry 2019; 6:620–630. 32. Edinoff AN, et al. Catatonia: clinical overview of the diagnosis, treatment, and clinical challenges. Neurol Int 2021; 13:570–586. 33. Wadi L, et  al. Electroconvulsive therapy for catatonia in anti-­NMDA receptor encephalitis: a case series. J Neuroimmunol 2024; 386:578271. 34. Pustilnik S, et al. Catatonia as the presenting symptom in systemic lupus erythematosus. J Psychiatr Pract 2011; 17:217–221. 35. Sundaram TG, et al. Catatonia in systemic lupus erythematosus: case based review. Rheumatol Int 2022; 42:1461–1476. 36. Lander M, et al. Review of withdrawal catatonia: what does this reveal about clozapine? Transl Psychiatry 2018; 8:139. 37. Sienaert P, et al. Adult catatonia: etiopathogenesis, diagnosis and treatment. Neuropsychiatry 2013; 3:391–399. 38. Huang TL, et  al. Lorazepam reduces the serum brain-­derived neurotrophic factor level in schizophrenia patients with catatonia. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33:158–159. 39. Sienaert P, et al. A clinical review of the treatment of catatonia. Front Psychiatry 2014; 5:181. 40. Fink M, et  al. Neuroleptic malignant syndrome is malignant catatonia, warranting treatments efficacious for catatonia. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30:1182–1183. 41. Lin CC, et al. The lorazepam and diazepam protocol for catatonia due to general medical condition and substance in liaison psychiatry. PLoS One 2017; 12:e0170452. 42. Javelot H, et al. Zolpidem test and catatonia. J Clin Pharm Ther 2015; 40:699–701. 43. Bastiampillai T, et al. Treatment refractory chronic catatonia responsive to zolpidem challenge. Aust N Z J Psychiatry 2016; 50:98. 44. Peglow S, et al. Treatment of catatonia with zolpidem. J Neuropsychiatry Clin Neurosci 2013; 25:E13. 45. Bush G, et al. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand 1996; 93:137–143. 46. Rosebush PI, et al. Catatonia: re-­awakening to a forgotten disorder. Mov Disord 1999; 14:395–397. 47. Ungvari GS, et al. Lorazepam for chronic catatonia: a randomized, double-­blind, placebo-­controlled cross-­over study. Psychopharmacology (Berl) 1999; 142:393–398. 48. Dutt A, et al. Phenomenology and treatment of catatonia: a descriptive study from north India. Indian J Psychiatry 2011; 53:36–40. 49. Zaman H, et al. Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses. Cochrane Database Syst Rev 2019; 8:CD006570. 50. Luchini F, et al. Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports. J Nerv Ment Dis 2013; 201:36–42. 51. Mishima T, et al. [Diazepam-­responsive malignant catatonia in a patient with an initial clinical diagnosis of neuroleptic malignant syndrome: a case report]. Brain Nerve 2011; 63:503–507. 52. Rodriguez S, et al. Neuroleptic malignant syndrome or catatonia? A case report. J Crit Care Med (Targu Mures) 2020; 6:190–193. 53. Fink M. Expanding the catatonia tent: recognizing electroconvulsive therapy responsive syndromes. J ECT 2021; 37:77–79. 54. Taylor MA, et al. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003; 160:1233–1241. 55. Cristancho P, et al. Successful use of right unilateral ECT for catatonia: a case series. J ECT 2014; 30:69–72. 56. Philbin D, et al. Catatonic schizophrenia: therapeutic challenges and potentially a new role for electroconvulsive therapy? BMJ Case Rep 2013; 2013:bcr2013009153. 57. Takebayashi M. [Electroconvulsive therapy in schizophrenia]. Nihon Rinsho 2013; 71:694–700. 58. Oviedo G, et al. Trends in the administration of electroconvulsive therapy for schizophrenia in Colombia: descriptive study and literature review. Eur Arch Psychiatry Clin Neurosci 2013; 263 Suppl 1:S98. 59. Pompili M, et al. Indications for electroconvulsive treatment in schizophrenia: a systematic review. Schizophr Res 2013; 146:1–9. 60. Ogando Portilla N, et al. Electroconvulsive therapy as an effective treatment in neuroleptic malignant syndrome: purposely a case. Eur Psychiatry 2013; 28 Suppl 1:1. 61. Unal A, et al. Effective treatment of catatonia by combination of benzodiazepine and electroconvulsive therapy. J ECT 2013; 29:206–209. 62. Kaliora SC, et al. The practice of electroconvulsive therapy in Greece. J ECT 2013; 29:219–224. 63. Girardi P, et al. Life-­saving electroconvulsive therapy in a patient with near-­lethal catatonia. Riv Psichiatr 2012; 47:535–537. 64. Kumar V, et al. Electroconvulsive therapy in pregnancy. Indian J Psychiatry 2011; 53 Suppl 5:S100–S101. 65. Weiss M, et al. Treatment of catatonia with electroconvulsive therapy in adolescents. J Child Adolesc Psychopharmacol 2012; 22:96–100. 66. Bauer J, et al. Should the term catatonia be explicitly included in the ICD-­10 description of acute transient psychotic disorder F23.0? Nord J Psychiatry 2012; 66:68–69. 67. Mohammadbeigi H, et al. Electroconvulsive therapy in single manic episodes: a case series. Afr J Psychiatry 2011; 14:56–59. 68. Dragasek J. [Utilisation of electroconvulsive therapy in treatment of depression disorders]. Psychiatrie 2011; 15:1211–1219. 69. Luchini F, et al. Electroconvulsive therapy in catatonic patients: efficacy and predictors of response. World J Psychiatry 2015; 5:182–192. 70. Lloyd JR, et al. Electroconvulsive therapy for patients with catatonia: current perspectives. Neuropsychiatr Dis Treat 2020; 16:2191–2208. 71. Breit S, et al. The effect of electroconvulsive therapy on specific catatonia symptoms and predictors of late response. Pharmacopsychiatry 2024; 57:13–­20.

160 The Maudsley® Prescribing Guidelines in Psychiatry CHAPTER 1 72. Sajith SG, et al. Response to electroconvulsive therapy in patients with autism spectrum disorder and intractable challenging behaviors associated with symptoms of catatonia. J ECT 2017; 33:63–­67. 73. van Waarde JA, et  al. Electroconvulsive therapy for catatonia: treatment characteristics and outcomes in 27 patients. J ECT 2010; 26:248–­252. 74. Jain A, et al. Catatonic Schizophrenia. StatPearls. Treasure Island (FL): StatPearls Publishing LLC; 2020. 75. Kellner CH, et al. Electroconvulsive therapy for catatonia. Am J Psychiatry 2010; 167:1127–­1128. 76. Xiao H, et al. Non-­invasive brain stimulation for treating catatonia: a systematic review. Front Psychiatry 2023; 14:1135583. 77. Hansbauer M, et al. rTMS and tDCS for the treatment of catatonia: a systematic review. Schizophr Res 2020; 222:73–­78. 78. Saini A, et al. Clozapine as a treatment for catatonia: a systematic review. Schizophr Res 2024; 263:275–­281. 79. Van Den EF, et al. The use of atypical antipsychotics in the treatment of catatonia. Eur Psychiatry 2005; 20:422–­429. 80. Caroff SN, et al. Movement disorders associated with atypical antipsychotic drugs. J Clin Psychiatry 2002; 63 Suppl 4:12–­19. 81. Guzman CS, et al. Treatment of periodic catatonia with atypical antipsychotic, olanzapine. Psychiatry Clin Neurosci 2008; 62:482. 82. Babington PW, et al. Treatment of catatonia with olanzapine and amantadine. Psychosomatics 2007; 48:534–­536. 83. Bastiampillai T, et al. Catatonia resolution and aripiprazole. Aust N Z J Psychiatry 2008; 42:907. 84. Strawn JR, et al. Successful treatment of catatonia with aripiprazole in an adolescent with psychosis. J Child Adolesc Psychopharmacol 2007; 17:733–735. 85. Kufert Y, et  al. Catatonic symptoms successfully treated with olanzapine in an adolescent with schizophrenia. J Child Adolesc Psychopharmacol 2021; 31:327–330. 86. Gazdag G, et al. Diagnosing and treating catatonia: an update. Curr Psychiatr Rev 2013; 9:130–135. 87. Spiegel DR, et al. A case of schizophrenia with catatonia resistant to lorazepam and olanzapine monotherapy but responsive to combination treatment: is it time to consider using select second-­generation antipsychotics earlier in the treatment algorithm for this patient type? Clin Neuropharmacol 2019; 42:57–59. 88. Cevher Binici N, et  al. Response of catatonia to amisulpride and lorazepam in an adolescent with schizophenia. J Child Adolesc Psychopharmacol 2018; 28:151–152. 89. Bilbily J, et al. Catatonia secondary to sudden clozapine withdrawal: a case with three repeated episodes and a literature review. Case Rep Psychiatry 2017; 2017:2402731. 90. Grover S, et al. Catatonia in systemic lupus erythematosus: a case report and review of literature. Lupus 2013; 22:634–638. 91. Rosebush PI, et al. Catatonia and its treatment. Schizophr Bull 2010; 36:239–242. 92. Caroff SN, et al. Movement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trial. Neurol Clin 2011; 29:127–148, viii. 93. Funayama M, et al. Catatonic stupor in schizophrenic disorders and subsequent medical complications and mortality. Psychosom Med 2018; 80:370–376. 94. Voros V, et al. [Use of aripiprazole in the treatment of catatonia]. Neuropsychopharmacol Hung 2010; 12:373–376. 95. Yoshimura B, et  al. Is quetiapine suitable for treatment of acute schizophrenia with catatonic stupor? A case series of 39 patients. Neuropsychiatr Dis Treat 2013; 9:1565–1571. 96. Todorova K. Olanzapine in the treatment of catatonic stupor -­ two case reports and discussion. Eur Neuropsychopharmacol 2012; 22 Suppl 2:S326. 97. Prakash O, et al. Catatonia and mania in patient with AIDS: treatment with lorazepam and risperidone. Gen Hosp Psychiatry 2012; 34:321–326. 98. Daniels J. Catatonia: clinical aspects and neurobiological correlates. J Neuropsychiatry Clin Neurosci 2009; 21:371–380. 99. Obregon DF, et al. Memantine and catatonia: a case report and literature review. J Psychiatr Pract 2011; 17:292–299. 100. Hervey WM, et al. Treatment of catatonia with amantadine. Clin Neuropharmacol 2012; 35:86–87. 101. Consoli A, et al. Lorazepam, fluoxetine and packing therapy in an adolescent with pervasive developmental disorder and catatonia. J Physiol Paris 2010; 104:309–314. 102. Lewis AL, et al. Malignant catatonia in a patient with bipolar disorder, B12 deficiency, and neuroleptic malignant syndrome: one cause or three? J Psychiatr Pract 2009; 15:415–422. 103. Padhy SK, et al. The catatonia conundrum: controversies and contradictions. Asian J Psychiatr 2014; 7:6–9.